As foreign interference and the prevalence of disinformation test our democratic processes, election administrators must work across the aisle to demonstrate a shared commitment to healthy election systems at all levels of government. This report provides a framework for effective bipartisan policies that balance the linchpins required equitable access and integrity of the results.
David Carroll, Mark P. Jones, John B. Williams, Doug Chapin, Adrián Carrasquillo Lecároz, Benjamin Ginsberg, Kim Wyman, Nellie Gorbea, Trey Grayson, David Becker, Avery Davis-RobertsFebruary 6, 2024
Legalizing recreational marijuana was intended to remedy the racially disparate effects of cannabis prohibition. But new research from our experts finds persistent racial disparities in the legal system’s practice of mandating treatment for cannabis use.
Katharine Neill Harris, Christopher F. KuleszaDecember 12, 2023
The energy policies of the United States and Mexico are at a crossroads, writes nonresident scholar Isidro Morales. In this report, he explains that the future direction of energy in both nations depends on how global energy markets adjust to the latest shock to the system — Russia’s invasion of Ukraine.
In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.
The authors examine recent trends in vaping, research on its effectiveness for smoking cessation, the role of industry marketing and policy responses to increased use.
Katharine Neill Harris, William MartinFebruary 28, 2020
In recent years public opinion surveys have found that a consistent and increasing percentage of Texans support marijuana reform, but this support has not translated into policy change. The authors explain why it should.
Katharine Neill Harris, William MartinApril 16, 2019
By providing regulated and safe access to medical cannabis to people with demonstrated need, the Texas Legislature can provide justified relief, help reduce the opioid epidemic, and save Texas millions of dollars, write the authors.
William Martin, Katharine Neill HarrisApril 15, 2019
Since 2001, the White House Transition Project has provided reports to incoming White House staff members on topics critical to a successful transfer of power. Written by presidential scholars from across the country, the series aims to enhance the staff’s understanding of day-to-day operations in the West and East wings. Nearly every former White House chief of staff, press secretary, director of communications, and senior advisor since the Nixon administration has been interviewed for the project to determine how each office operates — what works, what doesn't and what did they wish they had known before arriving at 1600 Pennsylvania Ave.? Other reports cover topics as diverse as the most effective use of the first 100 days and the dynamics of presidential travel.
The 2017 series is a partnership between the Moody Foundation, the White House Transition Project and the Baker Institute. It is led by Martha Joynt Kumar, an emeritus professor at Towson University and author of several books on the presidency, and Terry Sullivan, author and member of the political science faculty at the University of North Carolina at Chapel Hill, and was supported by a grant from the Moody Foundation.
The director of the White House Office of Science and Technology Policy (OSTP) plays a central role in advising the president on the impact of science and technology on domestic and global affairs, and on federal funding of scientific research. This paper provides recommendations for the next president to consider when choosing a science advisor and establishing science and technology policy priorities. The project also offers guidance to the next science advisor for developing effective policy while serving in the White House. The recommendations are based on lessons learned from past presidential science advisors as well as feedback from more than 60 reviewers, including individuals who currently serve or have served the OSTP, the President’s Council of Advisors for Science and Technology, federal agencies, Congress or congressional staff, and nongovernmental organizations as well as policy scholars.
Neal F. Lane, Kirstin R.W. Matthews, Kenneth M. EvansSeptember 12, 2016
State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.